BPC 157 has already hit the mainstream, but should it hit your bloodstream? Peptides, Drugs And Supplements: Science, Risks, And Alternatives Los Angeles Times The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Regeneration or Risk? A Narrative Review of BPC 157 for Musculoskeletal Healing Current Reviews in Musculoskeletal Medicine Springer Nature Link